Federal Investigators Reveal ‘Bombshell’: CDC & FDA Undertook ‘Politically Motivated’ Actions During Covid Pandemic
A federal investigation into Health and Human Services, National Institutes of Health, the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA) found that public health officials suppressed Covid study findings for political reasons, the Government Accountability Office (GAO) has revealed in a 37-page report.
GAO investigators inteviewed at least a dozen directors and managers who were involved in the agencies’ Covid guidance. The government watchdog found evidence of “political interference” in scientific reports.
“A few respondents from CDC and [Food and Drug Administration] FDA stated they felt that the potential political interference they observed resulted in the alteration or suppression of scientific findings,” GAO investigators found.
“Some of these respondents believed that this potential political interference may have resulted in the politically motivated alteration of public health guidance or delayed publication of Covid-related scientific findings,” they added.
The FDA notably did not issue an Emergency Use Authorization for a Covid-19 vaccine before the 2020 election, despite some insiders believing it might have been approved before Election Day (potentially costing Americans’ lives). Science magazine noted this concern in August 2020 in an article entitled, “Here’s how the U.S. could release a COVID-19 vaccine before the election—and why that scares some.”
“When President Donald Trump accepted his party’s nomination for another term last night at the Republican National Convention, he pledged that the push by his administration’s Operation Warp Speed to deliver a COVID-19 vaccine would succeed ‘before the end of the year, or maybe even sooner’,” Science reported.
“That promise concerns many vaccine veterans,” the story went on. “They worry that political forces—the U.S. presidential election on 3 November, nationalistic pride to ‘win’ a race, the need to resuscitate economies—could lead to premature and dangerous approvals under mechanisms such as the emergency use authorization (EUA), a pathway used by the U.S. Food and Drug Administration (FDA) to allow rapid access to diagnostics, treatments, and vaccines. Long a bastion of regulatory rigor that many other countries look to for guidance, FDA has been criticized for issuing EUAs for two COVID-19 treatments, convalescent plasma and hydroxychloroquine, based on scant data and apparent political pressure.”
The FDA would not issue a Covid-19 vaccine authorization prior to the 2020 election, raising questions about political decision-making.
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. Thank you for partnering with us to maintain fruitful conversation.